EPTIS
EPTIS
BAM Logo

Measurable Residual Disease for AML by Molecular Methods (not accredited)

EPTIS factsheet 941705 | Last revision 2022-10-28 | URL: https://www.eptis.bam.de/pts941705 https://www.eptis.bam.de/pts941705

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s) English
Remarks
Keywords
Product groups
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised cell preparation Presence/absence of t(8;21) (RUNX1::RUNX1T1) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Quantification of t(8;21) (RUNX1::RUNX1T1/reference gene %) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Presence/absence of inv(16) (CBFB::MYH11) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Quantification of inv(16) (CBFB::MYH11/reference gene %) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Presence/absence of t(15;17) (PML::RARA) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Quantification of t(15;17) (PML::RARA/reference gene %) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Presence/absence of NPM1 variants Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Quantification of NPM1 variants (NPM1/reference gene %) Molecular biology techniques for the analysis of RNA, including RTqPCR and RTdPCR
Aims of the PT scheme
Target group of participants Participation open to both UK and international laboratories.
Linked to specific legislation / standards ISO 17043:2010 ISO 13528:2015 ISO 15189:2012
Additional, subsidiary aims validation of testing methods
Number of participants 60
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UKNEQASLI for details
Regularly operated Yes (2 per annum (each send-out includes MRD positive and MRD negative samples))
Year of first operation 2021
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Fax:
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Stuart Scott
Phone: +44 (0) 114 2673600
Fax:
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Disclaimer & Privacy Policy
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5